9METERS BIOPHARMA
Dead / Abandoned — Abandoned — failure to respond (as of 17 Jul 2023)
What this means for you
This application is over — abandoned 03 Jul 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88573419
- Mark type
- Stylized text
- Filed
- 09 Aug 2019
- Published for opposition
- 24 Dec 2019
- Abandoned
- 03 Jul 2023
- Attorney of record
- Devon E. White
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms, namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form, namely, gels, ointments and pastes, suppositories, in liquid form, namely, drops, injectables, infusions, in gaseous form, namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Suppositories with proprietary delivery system for the precise delivery of drugs that target conditions and diseases of the anorectal region; Suppositories
Owner
- 9 METERS BIOPHARMA, RALEIGH, NC, US
- RDD Pharma, Inc., New York, NY, US
- RDD Pharma, Inc., New York, NY, US
Prosecution history
- 17 Jul 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 17 Jul 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 17 Jul 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 31 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2023 — NON-FINAL ACTION E-MAILED
- 31 Mar 2023 — SU - NON-FINAL ACTION - WRITTEN
- 04 Mar 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Feb 2023 — USE AMENDMENT FILED
- 20 Feb 2023 — TEAS STATEMENT OF USE RECEIVED
- 13 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2022 — SOU EXTENSION 5 GRANTED
- 04 Aug 2022 — SOU EXTENSION 5 FILED
- 04 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2022 — CORRECTED NOA E-MAILED